Dr Reddy's Laboratories today said it has launched Levetiracetram in Sodium Chloride injection, an anti-epileptic drug, in the US market.
The Hyderabad-based company's drug is the generic version of HQ Specialty Pharma Corporation's product , Dr Reddy's Laboratories said in a statement.
According to IMS Health data, Levetiracetam in Sodium Chloride injection brand and generics had sales of around USD 37 million in the US market.
Shares of Dr Reddy's were trading up 0.62 per cent up at Rs 2,395 on the BSE.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)